CXCR4 and adrenal cortex carcinoma: As such, in the present study, we aimed to determine whether CXCR4-targeting [68Ga]Ga-PentixaFor PET/CT can identify patients with metastasized ACC at increased risk for shorter overall survival (OS), in particular when compared to other established clinical parameters.